000 | 01058 a2200265 4500 | ||
---|---|---|---|
005 | 20250517130547.0 | ||
264 | 0 | _c20190808 | |
008 | 201908s 0 0 eng d | ||
022 | _a1463-1326 | ||
024 | 7 |
_a10.1111/dom.12842 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHome, Philip | |
245 | 0 | 0 |
_aComment on Abd El Aziz et al., A meta-analysis comparing clinical effects of short- or long-acting GLP-1 receptor agonists versus insulin treatment from head-to-head studies in type 2 diabetic patients. _h[electronic resource] |
260 |
_bDiabetes, obesity & metabolism _c02 2017 |
||
300 |
_a304-305 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aDiabetes Mellitus, Type 2 |
650 | 0 | 4 | _aGlucagon-Like Peptide-1 Receptor |
650 | 0 | 4 |
_aGlycated Hemoglobin _xanalysis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHypoglycemic Agents |
650 | 0 | 4 | _aInsulins |
773 | 0 |
_tDiabetes, obesity & metabolism _gvol. 19 _gno. 2 _gp. 304-305 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/dom.12842 _zAvailable from publisher's website |
999 |
_c26681925 _d26681925 |